Report cover image

Global Nicotinamide Phosphoribosyltransferase Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 191 Pages
SKU # APRC20560841

Description

Summary

According to APO Research, The global Nicotinamide Phosphoribosyltransferase market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Nicotinamide Phosphoribosyltransferase include OncoTartis, Inc., Karyopharm Therapeutics, Inc., Genentech, Inc., FORMA Therapeutics, Inc., Calico LLC, Aurigene Discovery Technologies Limited and Angelini Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nicotinamide Phosphoribosyltransferase, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Nicotinamide Phosphoribosyltransferase, also provides the sales of main regions and countries. Of the upcoming market potential for Nicotinamide Phosphoribosyltransferase, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nicotinamide Phosphoribosyltransferase sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Nicotinamide Phosphoribosyltransferase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Nicotinamide Phosphoribosyltransferase sales, projected growth trends, production technology, application and end-user industry.

Nicotinamide Phosphoribosyltransferase Segment by Company

OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Genentech, Inc.
FORMA Therapeutics, Inc.
Calico LLC
Aurigene Discovery Technologies Limited
Angelini Group
Nicotinamide Phosphoribosyltransferase Segment by Type

Lipids
Small Molecule Compounds
Hormone
Others
Nicotinamide Phosphoribosyltransferase Segment by Application

Breast Cancer
Parkinson's Disease
Acute Lung Injury
Others
Nicotinamide Phosphoribosyltransferase Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Phosphoribosyltransferase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Phosphoribosyltransferase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Phosphoribosyltransferase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Nicotinamide Phosphoribosyltransferase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Nicotinamide Phosphoribosyltransferase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nicotinamide Phosphoribosyltransferase sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Nicotinamide Phosphoribosyltransferase Market by Type
1.2.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Lipids
1.2.3 Small Molecule Compounds
1.2.4 Hormone
1.2.5 Others
1.3 Nicotinamide Phosphoribosyltransferase Market by Application
1.3.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Parkinson's Disease
1.3.4 Acute Lung Injury
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Nicotinamide Phosphoribosyltransferase Market Dynamics
2.1 Nicotinamide Phosphoribosyltransferase Industry Trends
2.2 Nicotinamide Phosphoribosyltransferase Industry Drivers
2.3 Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges
2.4 Nicotinamide Phosphoribosyltransferase Industry Restraints
3 Global Market Growth Prospects
3.1 Global Nicotinamide Phosphoribosyltransferase Revenue Estimates and Forecasts (2020-2031)
3.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Region
3.2.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2020-2025)
3.2.3 Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2026-2031)
3.2.4 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2020-2031)
3.3 Global Nicotinamide Phosphoribosyltransferase Sales Estimates and Forecasts 2020-2031
3.4 Global Nicotinamide Phosphoribosyltransferase Sales by Region
3.4.1 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region (2020-2025)
3.4.3 Global Nicotinamide Phosphoribosyltransferase Sales by Region (2026-2031)
3.4.4 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Manufacturers
4.1.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Manufacturers (2020-2025)
4.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Nicotinamide Phosphoribosyltransferase Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Nicotinamide Phosphoribosyltransferase Sales by Manufacturers
4.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Manufacturers (2020-2025)
4.2.2 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Nicotinamide Phosphoribosyltransferase Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Nicotinamide Phosphoribosyltransferase Sales Price by Manufacturers (2020-2025)
4.4 Global Nicotinamide Phosphoribosyltransferase Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Nicotinamide Phosphoribosyltransferase Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Nicotinamide Phosphoribosyltransferase Manufacturers, Product Type & Application
4.7 Global Nicotinamide Phosphoribosyltransferase Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Nicotinamide Phosphoribosyltransferase Market CR5 and HHI
4.8.2 2024 Nicotinamide Phosphoribosyltransferase Tier 1, Tier 2, and Tier 3
5 Nicotinamide Phosphoribosyltransferase Market by Type
5.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Type
5.1.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2020-2031)
5.2 Global Nicotinamide Phosphoribosyltransferase Sales by Type
5.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031) & (W Tons)
5.2.3 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2020-2031)
5.3 Global Nicotinamide Phosphoribosyltransferase Price by Type
6 Nicotinamide Phosphoribosyltransferase Market by Application
6.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Application
6.1.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2020-2031)
6.2 Global Nicotinamide Phosphoribosyltransferase Sales by Application
6.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031) & (W Tons)
6.2.3 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2020-2031)
6.3 Global Nicotinamide Phosphoribosyltransferase Price by Application
7 Company Profiles
7.1 OncoTartis, Inc.
7.1.1 OncoTartis, Inc. Comapny Information
7.1.2 OncoTartis, Inc. Business Overview
7.1.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
7.1.5 OncoTartis, Inc. Recent Developments
7.2 Karyopharm Therapeutics, Inc.
7.2.1 Karyopharm Therapeutics, Inc. Comapny Information
7.2.2 Karyopharm Therapeutics, Inc. Business Overview
7.2.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
7.2.5 Karyopharm Therapeutics, Inc. Recent Developments
7.3 Genentech, Inc.
7.3.1 Genentech, Inc. Comapny Information
7.3.2 Genentech, Inc. Business Overview
7.3.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
7.3.5 Genentech, Inc. Recent Developments
7.4 FORMA Therapeutics, Inc.
7.4.1 FORMA Therapeutics, Inc. Comapny Information
7.4.2 FORMA Therapeutics, Inc. Business Overview
7.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
7.4.5 FORMA Therapeutics, Inc. Recent Developments
7.5 Calico LLC
7.5.1 Calico LLC Comapny Information
7.5.2 Calico LLC Business Overview
7.5.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio
7.5.5 Calico LLC Recent Developments
7.6 Aurigene Discovery Technologies Limited
7.6.1 Aurigene Discovery Technologies Limited Comapny Information
7.6.2 Aurigene Discovery Technologies Limited Business Overview
7.6.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio
7.6.5 Aurigene Discovery Technologies Limited Recent Developments
7.7 Angelini Group
7.7.1 Angelini Group Comapny Information
7.7.2 Angelini Group Business Overview
7.7.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio
7.7.5 Angelini Group Recent Developments
8 North America
8.1 North America Nicotinamide Phosphoribosyltransferase Market Size by Type
8.1.1 North America Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2031)
8.1.2 North America Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031)
8.1.3 North America Nicotinamide Phosphoribosyltransferase Price by Type (2020-2031)
8.2 North America Nicotinamide Phosphoribosyltransferase Market Size by Application
8.2.1 North America Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2031)
8.2.2 North America Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031)
8.2.3 North America Nicotinamide Phosphoribosyltransferase Price by Application (2020-2031)
8.3 North America Nicotinamide Phosphoribosyltransferase Market Size by Country
8.3.1 North America Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Nicotinamide Phosphoribosyltransferase Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Nicotinamide Phosphoribosyltransferase Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Nicotinamide Phosphoribosyltransferase Market Size by Type
9.1.1 Europe Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2031)
9.1.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031)
9.1.3 Europe Nicotinamide Phosphoribosyltransferase Price by Type (2020-2031)
9.2 Europe Nicotinamide Phosphoribosyltransferase Market Size by Application
9.2.1 Europe Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2031)
9.2.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031)
9.2.3 Europe Nicotinamide Phosphoribosyltransferase Price by Application (2020-2031)
9.3 Europe Nicotinamide Phosphoribosyltransferase Market Size by Country
9.3.1 Europe Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Nicotinamide Phosphoribosyltransferase Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Nicotinamide Phosphoribosyltransferase Market Size by Type
10.1.1 China Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2031)
10.1.2 China Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031)
10.1.3 China Nicotinamide Phosphoribosyltransferase Price by Type (2020-2031)
10.2 China Nicotinamide Phosphoribosyltransferase Market Size by Application
10.2.1 China Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2031)
10.2.2 China Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031)
10.2.3 China Nicotinamide Phosphoribosyltransferase Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Nicotinamide Phosphoribosyltransferase Market Size by Type
11.1.1 Asia Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2031)
11.1.2 Asia Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031)
11.1.3 Asia Nicotinamide Phosphoribosyltransferase Price by Type (2020-2031)
11.2 Asia Nicotinamide Phosphoribosyltransferase Market Size by Application
11.2.1 Asia Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2031)
11.2.2 Asia Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031)
11.2.3 Asia Nicotinamide Phosphoribosyltransferase Price by Application (2020-2031)
11.3 Asia Nicotinamide Phosphoribosyltransferase Market Size by Country
11.3.1 Asia Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Nicotinamide Phosphoribosyltransferase Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Nicotinamide Phosphoribosyltransferase Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Nicotinamide Phosphoribosyltransferase Market Size by Type
12.1.1 SAMEA Nicotinamide Phosphoribosyltransferase Revenue by Type (2020-2031)
12.1.2 SAMEA Nicotinamide Phosphoribosyltransferase Sales by Type (2020-2031)
12.1.3 SAMEA Nicotinamide Phosphoribosyltransferase Price by Type (2020-2031)
12.2 SAMEA Nicotinamide Phosphoribosyltransferase Market Size by Application
12.2.1 SAMEA Nicotinamide Phosphoribosyltransferase Revenue by Application (2020-2031)
12.2.2 SAMEA Nicotinamide Phosphoribosyltransferase Sales by Application (2020-2031)
12.2.3 SAMEA Nicotinamide Phosphoribosyltransferase Price by Application (2020-2031)
12.3 SAMEA Nicotinamide Phosphoribosyltransferase Market Size by Country
12.3.1 SAMEA Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Nicotinamide Phosphoribosyltransferase Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Nicotinamide Phosphoribosyltransferase Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Nicotinamide Phosphoribosyltransferase Value Chain Analysis
13.1.1 Nicotinamide Phosphoribosyltransferase Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Nicotinamide Phosphoribosyltransferase Production Mode & Process
13.2 Nicotinamide Phosphoribosyltransferase Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Nicotinamide Phosphoribosyltransferase Distributors
13.2.3 Nicotinamide Phosphoribosyltransferase Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.